Abstract
Current echocardiography techniques have allowed more precise assessment of cardiac structure and function of the several types of cardiomyopathies. Parameters derived from echocardiographic tissue imaging (ETI)—tissue Doppler, strain, strain rate, and others—are extensively used to provide a framework in the evaluation and management of cardiomyopathies. Generally, myocardial function assessed by ETI is depressed in all types of cardiomyopathies, non-ischemic dilated cardiomyopathy (DCM) in particular. In hypertrophic cardiomyopathy (HCM), ETI is useful to identify subclinical disease in family members of HCM, to differentiate HCM from other conditions causing cardiac hypertrophy and to predict cardiac events. ETI also for HCM allows addressing the mechanism behind left ventricular outflow tract obstruction and its improvement after therapeutic options. ETI provides cardiac amyloidosis with unique and specific findings such as “apical sparing.” Nevertheless, ETI does not seem to provide as much information amenable to histological findings as recently emerging techniques of cardiac magnetic resonance imaging. This review introduces usefulness of ETI and some other ultrasound techniques for detecting clinical and subclinical characteristics of cardiomyopathies, focusing on DCM, HCM, and cardiac amyloidosis.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Advanced imaging techniques have allowed not only more precise assessment for the severity of cardiovascular diseases, but also earlier detection of changes in the cardiac structure and function. Cardiac magnetic resonance (CMR) imaging has progressively emerged as a diagnostic tool, although it remains to be completely resolved regarding a lack of availability, portability, and cost-effectiveness. On the other hand, because of its ability to provide real-time images combined with high spatial and temporal resolution, echocardiography is invaluable for assessing chamber size, wall thickness, and systolic and diastolic function, which allows diagnostic, therapeutic, and prognostic considerations in various clinical conditions. Among patients with known or suspected cardiomyopathy in which myocardial ischemia is hardly involved as pathogenesis, the advent of echocardiographic tissue imaging (ETI), including tissue Doppler, strain, and strain rate, has provided information on the aforementioned matters in addition to better understanding of global and regional myocardial mechanics.
In this review, we discuss usefulness of ETI and other ultrasound techniques (Table 1) for detecting clinical and subclinical characteristics of cardiomyopathies, focusing on non-ischemic dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and cardiac amyloidosis (CA), all of which have the myocardium diffusely affected. We also refer to some about “postsystolic shortening (PSS),” which is a unique phenomenon of the myocardial mechanics occurring even in a non-ischemic etiology, and considered to be important in defining cardiac function.
Dilated cardiomyopathy
DCM is characterized by an increased chamber size and diffusely compromised contractile function of the ventricle. Impairment of diastolic function is also common. These abnormalities can be expressed by most of the findings on ETI. In DCM, tissue Doppler imaging (TDI)-derived indices of systolic (s′), early diastolic (e′), and late diastolic (a′) annular velocities, all reflective of longitudinal fiber function, are attenuated. E/e′ serves to substitute for left ventricular (LV) filling pressure and thus to guide treatment strategies especially in patients with reduced LV ejection fraction [1]. Among patients with ischemic and non-ischemic cardiomyopathy, depression of s′ (< 3.0 cm/s) and e′ (< 3.0 cm/s) was reported to be associated with worsening of outcome [2].
At the advanced stage of disease process, TDI components can be recorded chaotic in both amplitude and timing (Fig. 1). Such a finding seems to indicate a condition of end-stage DCM involved with extensive structural and electrical derangement of the myocardium, although more research is needed to determine its clinical significance.
Strain and strain rate techniques, based on both TDI and speckle tracking echocardiography (STE), provide measures on myocardial deformation. Generally, compared with normal individuals, DCM patients have decreased global and regional strain with a large variability of strain values between myocardial segments [3, 4]. DCM is associated with high prevalence of myocardial segments with postsystolic shortening (PSS) [5], the details of which are explained later. Such functional damages of the myocardium were found to improve with appropriate heart failure treatment [5, 6].
Impaired myocardial deformation, indicated by a decreased global longitudinal strain (GLS), has been shown to be associated with incremental prognostic information to LV ejection fraction in DCM patients [7]. GLS plays an important role in detecting subclinical myocardial damage and preventing progression to overt symptomatic heart failure [8]. Particularly, in patients undergoing chemotherapy, the measurement of GLS is recommended in the standard echocardiography protocols [9].
Three-dimensional speckle tracking echocardiography
Two-dimensional STE (2D-STE) has several limitations such as beat-by-beat alteration of cardiac function particularly in case of unstable cardiac conditions and disappearance of some speckles within the region of interest during a cardiac cycle referring to as “out-of-plane phenomenon” [10]. Because of the full-volume data acquisition, 3D-STE is expected to cover aforementioned limitations on 2D-STE, and thus has the potential for more detailed assessment of global and regional myocardial function than 2D-STE. 3D-STE also allows easier data acquisition and analysis for complicated measures of LV function such as dyssynchrony and twisting, and even for those of the right ventricle [10,11,12].
In a small number of children with DCM, Balasubramanian et al. showed that 3D-STE was superior to 2D-STE in terms of reproducibility measurement [13]. Similar to 2D-STE, 3D-STE provides DCM patients with lower strain values for three directions of the strain (longitudinal, circumferential, and radial) compared with healthy individuals [14]. With anaysis of torsional mechanics, 3D-STE was shown to discriminate DCM patients with wide QRS complex from those with narrow QRS complex [15].
Figure 2 shows a 3D-STE image from a patient with DCM, where global and regional strain values are decreased overall, with some of the myocardial segments associated with PSS.
Postsystolic shortening
PSS is a phenomenon of myocardial contraction that occurs or sustains after the end of the ejection phase [16]. It can be assessed by TDI, strain, and strain rate not only in patients with ischemic myocardium but also in those with non-ischemic etiologies and even in normal individuals [5, 17,18,19]. With strain analysis, PSS is defined when the strain after end-systole (after aortic valve closure) is greater than that at end-systole (Fig. 3). Both clinical and experimental studies found that PSS was correlated with LV diastolic function and diminished with appropriate interventions [5, 18, 20]. Figure 4 shows bull’s eye displays of postsystolic index mapping before and after effective medical treatment in a DCM patient.
The underlying mechanism of PSS remains to be elucidated. Claus et al. and later Bijnens et al. proposed that occurrence of myocardial deformation after aortic valve closure is caused by an imbalance in thickness between the segment that would develop PSS and the surrounding segments [21, 22]. PSS is initiated by a sudden decrease in LV pressure, which changes the balance between the forces acting locally on a myocardial segment and leads to thickening while the surrounding segments thin. It is also suggested that under conditions of preserved myocardial elasticity (not scarred), the amount of PSS is related to the amount of imbalance between the myocardial contractility of a segment and that of the surrounding segments [21].
“Pre-ejection stretch,” a pattern of myocardial deformation occurring even in a normal heart, may contribute to development of PSS [23] (Fig. 5). This phenomenon is considered to represent a precondition to optimize initial tension of the myocardium for the subsequent contraction and to play a pivotal role in determining synchronous myocardial motion [24]. In more severe condition of impaired LV systolic function, however, appearance and behavior of pre-systolic stretch in relation to PSS does not seem to be coherent (Fig. 1). Further work is needed to clarify significance of pre-ejection stretch and its relevance to PSS in various clinical settings.
Hypertrophic cardiomyopathy
During systole, LV contraction is initiated by shortening of longitudinal and circumferential myocardial fibers and by thickening of radial myocardial fibers [25, 26]. In HCM, besides reduced longitudinal shortening, circumferential fiber shortening is preserved or even exaggerated, reportedly shown by both TDI and STE [27, 28], perhaps in order to counterbalance the reduction of longitudinal fiber shortening. This, in HCM patients, indicates that the measurement of LV ejection fraction is largely dependent on the quantification of circumferential fiber shortening, and thus attention should be paid not to underestimate the degree of systolic impairment. Longitudinal shortening may play an important role in determining early myopathic process based on the finding that longitudinal fiber myocardial deformation was linked to myocardial disarray [29, 30].
Among asymptomatic or mildly symptomatic patients with HCM, Kitaoka et al. found that those who experienced cardiovascular events including death and heart failure admission had low e′ and a′ compared with those who did not [31]. TDI-derived s′ is reduced despite normal or supernormal LV ejection fraction, even for the myocardial segments not demonstrating overt hypertrophy [32]. These findings may relate to the presence of interstitial fibrosis, cardiomyocyte hypertrophy, and impaired coronary microcirculation [33, 34].
There has been an intriguing observation that TDI-derived s′ and e′ enable to identify subclinical disease involved with adolescent subjects from HCM families who have been yet to demonstrate phenotypic hypertrophy [35]. This observation implies that repeated imaging, hopefully at yearly interval, is essential to find out later development of LV hypertrophy. In contrast, a study from Netherland found that both s′ and e′ were not so sufficiently sensitive for screening family members in the HCM population [36], although a large-scale study would be warranted to solve such discrepancies between the studies.
The left atrial (LA) longitudinal strain represents an excellent parameter for analyzing LA function in several conditions [37]. Aly et al. demonstrated that along with information on LA volumes, decreased peak atrial longitudinal strain (PALS) was useful to detect early myocardial changes in mutation carriers of HCM [38]. Given that no changes in global LV function were observed and that LA dysfunction is the first manifestation of LV diastolic dysfunction [38], 3D-STE would become crucial for differentiating HCM carriers from non-carrier individuals.
As HCM is a common cause of premature sudden cardiac death leading to increased mortality, identification of the underlying etiology of LV hypertrophy is of clinical importance. TDI helps differentiate various conditions resulting in LV hypertrophy. A cut-off value of s′ < 9.0 cm/s, averaged for the septal and lateral mitral annulus, was shown to differentiate pathological LV hypertrophy (due to HCM or hypertensive heart disease) from physiological LV hypertrophy [39]. However, diagnosing HCM seemed to be difficult only with TDI, especially in elderly patients with mild concentric LV hypertrophy [40]. Using strain rate, Kato et al. proposed combined use of reduced longitudinal shortening and presence of asymmetric hypertrophy to identify biopsy-proven HCM patients apart from hypertensive patients [40].
Diastolic dysfunction
Diastolic function comprises continuum of early relaxation and late compliance [41]. Impairment of ventricular relaxation is a hallmark of HCM. With TDI, e′ is considered as a measure of early relaxation whereas a′ as a measure of late compliance. To the best of our knowledge, there is no convincing evidence on late compliance in HCM such that a′ enables to detect subclinical cardiac damage, to estimate LV filling pressures, or to predict clinical outcome. This is presumably because HCM has a specific myocardial/chamber property during diastole [42].
Pak et al. observed in a hemodynamic study that pressure-volume relationship in HCM was quite different from that in hypertensive heart disease, the former demonstrating that with volume overloading, the pressure-volume curve shifts superiorly with the rightward shift only a little [42]. Such a complexity of diastolic property, in HCM, may render introduction of robust markers for late compliance challenging. In HCM patients, both Doppler LV filling and pulmonary venous flow profiles are not as reliable for the non-invasive estimation of LV filling pressures as in DCM patients [43, 44].
On the other hand, in HCM, TDI-derived e′ is established as an index of myocardial relaxation, functional status, in addition to the degree of myocardial fibrosis [1], and E/e′ represents a non-invasive estimation of LV filling pressures [45]. Recently, the global strain rate during early diastole of the left ventricle (e′sr) has been proposed to assess LV filling pressures [19, 46]. It was augured that the e′sr had an advantage over E/e′ in terms of the coverage of the entire endocardium being assessed [19, 46]. Further investigations are needed to clarify relative usefulness of such a new index to E/e′ for cardiomyopathies.
Color kinesis (CK) is a real-time ultrasound technique providing information on the magnitude and timing of LV wall motion by tracking and color-encoding endocardial motion during the cardiac cycle [47]. CK has great usefulness particularly in the evaluation of LV relaxation [48]. Another strength of CK may be providing at-a-glance recognition of which LV segment has slowed relaxation. A study of HCM showed that CK imaged the regional LV filling time prolonged even in the non-hypertrophied segments [49].
Postsystolic shortening in hypertrophic cardiomyopathy
As mentioned, HCM patients tend to be accompanied by non-uniformity of regional systolic function; however, information on PSS in these patients is limited. A group of ours found that HCM patients had PSS in the considerable extent of LV wall with its magnitude being increased compared with normal controls [18]. This is in turn supportive of HCM patients being involved with myocardial disarray and fibrosis with various distributions of myocyte hypertrophy. There was an interesting observation that in patients with hypertrophic obstructive cardiomyopathy (HOCM), PSS attenuated after alcohol septal ablation, the degree of which correlated with E/e′ [50].
Apical asynergy with cavity obliteration of the left ventricle is a unique associate in HCM. The dyskinetic apical region may account for thrombus formation [51]. In one third of the cases, a paradoxical flow toward the left ventricular outflow tract (LVOT) during early diastole resulting from intraventricular obstruction is detected [51]. With TDI-based strain and strain rate analysis, Støylen et al. observed that the myocardium of the apical region associated with delayed relaxation and subsequent contraction during early diastole (PSS in a broad sense) was accounting for the paradoxical flow [52].
Figure 6 presents cardiac images from a case of HCM with apical cavity obliteration we experienced before. There is a paradoxical flow toward the LVOT with duration extending into early diastole, during which PSS is recorded both with TDI and strain rate methods.
Left ventricular outflow tract obstruction
About one third of HCM patients have systolic anterior motion of the mitral valve, a phenomenon involving most commonly the anterior mitral valve leaflet [53]. Mechanistically, it occurs as result of drag forces and the Venturi effect, which pushes and drags, respectively, the leaflets into the LVOT, thereby resulting in septal-mitral contact and subsequent LVOT obstruction [53]. However, detailed myocardial mechanics accompanied by this phenomenon have merely been evaluated.
Recently, with STE-based strain utilized in HOCM patients, Giraldeau et al. found that LV dyssynchrony induced by biventricular pacing was associated with reduced LVOT pressure gradient at 12 months follow-up without deterioration of LV ejection fraction or GLS [54]. The mechanism of which was implied as earlier recruitment of the LV free wall into systole and concomitantly released LVOT obstruction by the pacing, resulting in the preserved LV systolic function [54].
Other investigators proposed utilization of right ventricular pacing to attenuate LVOT obstruction by inducing “longitudinal” LV dyssynchrony, as determined by TDI, especially for the ventricular septum [55]. During a pacing study combined with TDI-based strain and strain rate analysis, in addition, it was shown that the myocardium of the basal septum “shortened” during OFF-mode pacing and “lengthened” during ON-mode pacing, with the OFF-mode setting being associated with greater LVOT pressure gradient [56].
Studies observed that HOCM patients who underwent alcohol septal ablation for intractable LVOT obstruction had improvement of ETI-assessed cardiac function [57, 58], supporting the notion that alcohol septal ablation gives more functional and prognostic benefit to HOCM patients than dual-chamber pacing, in which both systolic and diastolic function can be deteriorated after the procedure [59, 60]. In addition, LA function was shown to improve after septal ablation therapy in HOCM patients [61].
Tissue characterization by ultrasound integrated backscatter
About two decades ago, when TDI still was not clinically available, myocardial tissue characterization using echocardiographic integrated backscatter (IB) had attracted researchers in the field of cardiac ultrasound. A finding of IB enabling to detect rejection against a cardiac allograft used to be astonishing [62]. There were two parameters analyzed with this technique: IB intensity and cyclic variation of IB, the former reflecting the degree of myocyte hypertrophy or myocardial fibrosis, and the latter regional myocardial function.
A group of ours demonstrated in DCM patients that IB intensity, but not cyclic variation, discriminated patients who responded to beta-blocker therapy from those who did not [63], and that elevated IB intensity was associated with a higher rate of cardiac death or worsening of heart failure [64]. For HCM patients, it was found that IB intensity was increased and the cyclic variation was decreased, a finding of which was clearly different when compared with hypertensive patients [65].
Figure 7 shows the result of IB analysis from a patient with HCM in contrast to a normal subject.
T1-mapping by cardiac magnetic resonance
The degree of myocardial fibrosis as an arrhythmogenic substrate is an important clinical consideration in the management of HCM patients. The late gadolinium enhancement (LGE) on CMR is sensitive to the finding of fibrotic lesions [66]. T1-mapping, an emerging technique of CMR, is also useful to detect interstitial fibrosis [67]. Notably, T1-mapping provides us with data that are not currently available with ETI. For example, a decrease in native T1 value is highly specific to detect disease severity related to myocardial iron overload or glycosphingolipid accumulation in Anderson-Fabry disease, whereas an elevated native T1 value is observed in HCM, amyloidosis, and other conditions associated with intercellular edema [67].
Several reports have evaluated usefulness of T1-mapping for diagnosing HCM and assessing its severity. It was reported that the native T1 value was increased in known HCM patients than normal controls, and that among HCM patients, LV segments with LGE were associated with higher native T1 value than those without LGE [68]. In a multicenter study, T1-mapping was found to discriminate HCM from hypertensive heart disease and to detect early changes in family members with sarcomere-gene mutations [69]. Unfortunately though, there have been no studies on HCM that compare early detection of the disease by CMR versus ETI.
Figure 8 shows images of native T1-mapping and the bull’s eye display of longitudinal strain from a patient with HCM, in contrast to those from a patient with light-chain CA.
Cardiac amyloidosis
CA is involved with the aggregation of insoluble deposits of misfolded proteins. The echocardiographic findings of CA include increased wall thickness with normal or mildly decreased LV ejection fraction, restrictive LV filling pattern, and dilated atria [70]. The amyloid deposits occasionally show a granular sparkling with increased granular myocardial echogenicity [70]. Only with conventional methodologies, however, the differentiation of CA from other types of cardiomyopathies such as HCM and hypertensive heart disease is not always straightforward. ETI, in that point, may come into play [71,72,73].
Given that regional systolic and diastolic dysfunction is the main feature of functional abnormality in CA, TDI, strain, and strain rate represent marked decreases in parameters derived even in the absence of restrictive physiology [72, 73]. STE has proven to be useful in distinguishing CA patients. In contrast to HCM and hypertensive heart disease, CA tends to be characterized by a distinctive pattern of regional variations in myocardial deformation, with relative sparing of function in the apical segments [71]. This finding is referred to as “apical sparing” (Figs. 8 and 9). Moreover, CA has been reported to be associated with decreased circumferential strain compared with HCM patients (Fig. 10), although GLS is impaired in both conditions [71]. One would see how easily recognizable on apical sparing and circumferential strain reduction in CA patients, seemingly an accurate means for segregating CA from HCM patients.
Assessment of myocardial mechanics utilizing 3D-STE on 12 CA patients showed that the more pronounced LGE detected on CMR, the lower myocardial strains to the corresponding segments [74]. A pattern of marked LGE from the base to apex may render such a finding more likely to result from CA rather than HCM, although further information is warranted to understand and differentiate these two conditions with a large number of patients.
Atrial involvement
Atrial involvement is also common in CA patients and may cause “restrictive” LV filling in terms of the A-wave velocity reduction. Analysis of LA strain and/or strain rate to differentiate CA from HCM patients has been performed by several investigators. It was found that PALS was attenuated to a more extent in transthyretin-related CA compared with HCM despite comparable alterations of LA volume and LV ejection fraction [75]. In a study of various types of CA (light chain, transthyretin with mutant, and transthyretin with wild type), Nochioka et al. demonstrated that transthyretin with wild type had worse LA reservoir and pump function than other types of CA [76]. The authors also found the severity of LA function to correlate with parameters of LV function such as E/e′ and longitudinal strain and suggested that in CA, LA function did not deteriorate independently, but did to a greater or lesser extent under influence of altered LV function [76].
There are few studies on CA patients that examined LA function with 3D-STE [77, 78]. Using 3D-STE, Mohty et al. demonstrated that PALS and total LA emptying fraction were correlated with the Mayo Clinic staging, which was based on the finding of NT-proBNP and cardiac troponin T levels, and that decreases in these LA indices were associated with 2-year mortality [78].
Prolongation of intra- and interatrial conduction time with heterogeneous propagation of the sinus impulses is a pathological feature of the atria leading to atrial arrhythmia. Recent studies have shown that the time interval between the beginning of electrocardiogram P wave and the beginning of TDI-derived a′ (atrial electromechanical delay: AEMD) (Fig. 11) relates to AF development, suggesting that AEMD reflects AF vulnerability [79, 80].
In CA patients, there should be a considerable degree of AEMD prolongation, because the myocardium with infiltrated amyloid proteins and the alteration of loading conditions lead to functional and structural changes not only on ventricles but also on atria; however, very scarce information exists on AEMD in CA [81]. Iio et al. calculated AEMD by STE, but not TDI, in patients with CA and in those with HCM, and found that the lateral wall EMD was recorded longer in CA patients being associated with a higher mortality rate [81].
Figure 12 shows ETI images from a CA patient. There is a marked prolongation of AEMD, with TDI-derived a′ existing beyond the QRS complex such that the LV filling is looking like a fusion wave.
Conclusions
In this review, we highlight echocardiographic findings in relatively common types of cardiomyopathies (DCM, HCM, and CA) and discuss which ETI methodology or index can be used in accordance with clinical, morphological, and functional features inherent to each type of cardiomyopathy. For example, global systolic dysfunction for DCM, impairment of regional systolic and diastolic function for HCM, and significant atrial involvement for CA. Contemporary progression of ultrasound technologies over ETI seems to allow even better understanding of cardiac characteristics and function. Utilization of STE is rapidly glowing and particularly, implementation of 3D-STE has potential to provide an optimal and homogenous application for strain measurements. We hope that further development of technologies regarding ETI will enable to quantitate deformation measurements reflecting the degree of structural alterations, myocardial fibrosis, and even chamber/myocardial stiffness.
References
Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quiñones MA (1997) Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30:1527–1533
Wang M, Yip G, Yu CM, Zhang Q, Zhang Y, Tse D, Kong SL, Sanderson JE (2005) Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 45:272–277. https://doi.org/10.1016/j.jacc.2004.09.059
Amorim S, Rodrigues J, Campelo M, Moura B, Martins E, Macedo F, Silva-Cardoso J, Maciel MJ (2017) Left ventricular reverse remodeling in dilated cardiomyopathy: maintained subclinical myocardial systolic and diastolic dysfunction. Int J Card Imaging 33:605–613. https://doi.org/10.1007/s10554-016-1042-6
den Boer SL, du Marchie Sarvaas GJ, Klitsie LM, van Iperen GG, Tanke RB, Helbing WA, Backx APCM, Rammeloo LAJ, Dalinghaus M, Ten Harkel ADJ (2017) Distribution of strain patterns in children with dilated cardiomyopathy. Echocardiography 34:881–887. https://doi.org/10.1111/echo.13548
Ito T, Kawanishi Y, Futai R, Terasaki F, Kitaura Y (2009) Usefulness of carvedilol to abolish myocardial postsystolic shortening in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 104:1568–1573. https://doi.org/10.1016/j.amjcard.2009.07.028
Takemoto Y, Hozumi T, Sugioka K, Takagi Y, Matsumura Y, Yoshiyama M, Abraham TP, Yoshikawa J (2007) Beta-blocker therapy induces ventricular resynchronization in dilated cardiomyopathy with narrow QRS complex. J Am Coll Cardiol 49(7):778–783
Stanton T, Leano R, Marwick TH (2009) Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging 2:356–364. https://doi.org/10.1161/CIRCIMAGING.109.862334
Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351–369. https://doi.org/10.1016/j.echo.2010.02.015
Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63:2751–2768. https://doi.org/10.1016/j.jacc.2014.01.073
Seo Y, Ishizu T, Atsumi A, Kawamura R, Aonuma K (2014) Three-dimensional speckle tracking echocardiography. Circ J 78:1290–1301
Sveric KM, Ulbrich S, Rady M, Ruf T, Kvakan H, Strasser RH, Jellinghaus S (2017) Three-dimensional left ventricular torsion in patients with dilated cardiomyopathy: a marker of disease severity. Circ J 81:529–536. https://doi.org/10.1253/circj.CJ-16-0965
Ishizu T, Seo Y, Atsumi A, Tanaka YO, Yamamoto M, Machino-Ohtsuka T, Horigome H, Aonuma K, Kawakami Y (2017) Global and regional right ventricular function assessed by novel three-dimensional speckle-tracking echocardiography. J Am Soc Echocardiogr 30:1203–1213. https://doi.org/10.1016/j.echo.2017.08.007
Balasubramanian S, Punn R, Smith SN, Houle H, Tacy TA (2017) Left ventricular systolic myocardial deformation: a comparison of two- and three-dimensional echocardiography in children. J Am Soc Echocardiogr 30:974–983. https://doi.org/10.1016/j.echo.2017.06.006
Duan F, Xie M, Wang X, Li Y, He L, Jiang L, Fu Q (2012) Preliminary clinical study of left ventricular myocardial strain in patients with non-ischemic dilated cardiomyopathy by three-dimensional speckle tracking imaging. Cardiovasc Ultrasound 10:8. https://doi.org/10.1186/1476-7120-10-8
Matsumoto K, Tanaka H, Tatsumi K, Miyoshi T, Hiraishi M, Kaneko A, Tsuji T, Ryo K, Fukuda Y, Yoshida A, Kawai H, Hirata K (2012) Left ventricular dyssynchrony using three-dimensional speckle-tracking imaging as a determinant of torsional mechanics in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 109:1197–1205. https://doi.org/10.1016/j.amjcard.2011.11.059
Brown MA, Norris RM, Takayama M, White HD (1987) Postsystolic shortening: a marker of potential for early recovery of acutely ischemic myocardium in the dog. Cardiovasc Res 21:703–716
Voigt JU, Lindenmeier G, Exner B, Regenfus M, Werner D, Reulbach U, Nixdorff U, Flachskampf FA, Daniel WG (2003) Incidence and characteristics of segmental postsystolic longitudinal shortening in normal, acutely ischemic, and scarred myocardium. J Am Soc Echocardiogr 16:415–423
Ito T, Suwa M, Tonari S, Okuda N, Kitaura Y (2006) Regional postsystolic shortening in patients with hypertrophic cardiomyopathy: its incidence and characteristics assessed by strain imaging. J Am Soc Echocardiogr 19:987–993
Nogi S, Ito T, Kizawa S, Shimamoto S, Sohmiya K, Hoshiga M, Ishizaka N (2016) Association between left ventricular postsystolic shortening and diastolic relaxation in asymptomatic patients with systemic hypertension. Echocardiography 33:216–222. https://doi.org/10.1111/echo.13022
Urheim S, Edvardsen T, Steine K, Skulstad H, Lyseggen E, Rodevand O, Smiseth OA (2003) Postsystolic shortening of ischemic myocardium: a mechanism of abnormal intraventricular filling. Am J Physiol Heart Circ Physiol 284:H2343–H2350
Claus P, Weidemann F, Dommke C, Bito V, Heinzel FR, D’hooge J, Sipido KR, Sutherland GR, Bijnens B (2007) Mechanisms of postsystolic thickening in ischemic myocardium: mathematical modeling and comparison with experimental ischemic substrates. Ultrasound Med Biol 33:1963–1970
Bijnens B, Claus P, Weidemann F, Strotmann J, Sutherland GR (2007) Investigating cardiac function using motion and deformation analysis in the setting of coronary artery disease. Circulation 116:2453–2464
Bogunovic N, van Buuren F, Esdorn H, Horstkotte D, Bogunovic L, Faber L (2018) Physiological left ventricular segmental myocardial mechanics: multiparametric polar mapping to determine intraventricular gradients of myocardial dynamics. Echocardiography 35:1947–1955. https://doi.org/10.1111/echo.14191
Sengupta PP (2008) Exploring left ventricular isovolumic shortening and stretch mechanics: “the heart has its reasons...”. JACC Cardiovasc Imaging 2(2):212–215. https://doi.org/10.1016/j.jcmg.2008.12.005
Waldman LK, Nosan D, Villarreal F, Covell JW (1988) Relation between transmural deformation and local myofiber direction in canine left ventricle. Circ Res 63:550–562
Gorcsan J 3rd, Tanaka H (2011) Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 58:1401–1413. https://doi.org/10.1016/j.jacc.2011.06.038
Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, Rakowski H (2008) Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr 21:675–683. https://doi.org/10.1016/j.echo.2007.10.021
Sengupta PP, Narula J (2012) LV segmentation and mechanics in HCM: twisting the Rubik’s cube into perfection! JACC Cardiovasc Imaging 5:765–768. https://doi.org/10.1016/j.jcmg.2012.05.009
Wang TT, Kwon HS, Dai G, Wang R, Mijailovich SM, Moss RL, So PT, Wedeen VJ, Gilbert RJ (2010) Resolving myoarchitectural disarray in the mouse ventricular wall with diffusion spectrum magnetic resonance imaging. Ann Biomed Eng 38:2841–2850. https://doi.org/10.1007/s10439-010-0031-5
Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ (2001) Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 104:128–130
Kitaoka H, Kubo T, Hayashi K, Yamasaki N, Matsumura Y, Furuno T, Doi YL (2013) Tissue Doppler imaging and prognosis in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 14:544–549. https://doi.org/10.1093/ehjci/jes200
Shan K, Bick RJ, Poindexter BJ, Shimoni S, Letsou GV, Reardon MJ, Howell JF, Zoghbi WA, Nagueh SF (2000) Relation of tissue Doppler derived myocardial velocities to myocardial structure and beta-adrenergic receptor density in humans. J Am Coll Cardiol 36:891–896
Kalra A, Harris KM, Maron BA, Maron MS, Garberich RF, Haas TS, Lesser JR, Maron BJ (2016) Relation of Doppler tissue imaging parameters with heart failure progression in hypertrophic cardiomyopathy. Am J Cardiol 117(11):1808–1814. https://doi.org/10.1016/j.amjcard.2016.03.018
Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG (2006) Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1043–1048
Nagueh SF, McFalls J, Meyer D, Hill R, Zoghbi WA, Tam JW, Quiñones MA, Roberts R, Marian AJ (2003) Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation 108:395–398
Michels M, Soliman OI, Kofflard MJ, Hoedemaekers YM, Dooijes D, Majoor-Krakauer D, ten Cate FJ (2008) Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging 2:58–64. https://doi.org/10.1016/j.jcmg.2008.08.003
Cameli M, Mandoli GE, Loiacono F, Dini FL, Henein M, Mondillo S (2016) Left atrial strain: a new parameter for assessment of left ventricular filling pressure. Heart Fail Rev 21:65–76. https://doi.org/10.1007/s10741-015-9520-9
Aly MF, Brouwer WP, Kleijn SA, van Rossum AC, Kamp O (2014) Three-dimensional speckle tracking echocardiography for the preclinical diagnosis of hypertrophic cardiomyopathy. Int J Card Imaging 30:523–533. https://doi.org/10.1007/s10554-014-0364-5
Vinereanu D, Florescu N, Sculthorpe N, Tweddel AC, Stephens MR, Fraser AG (2001) Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 88:53–58
Kato TS, Noda A, Izawa H, Yamada A, Obata K, Nagata K, Iwase M, Murohara T, Yokota M (2004) Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 110:3808–3814
Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure: abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350:1953–1959
Pak PH, Maughan L, Baughman KL, Kass DA (1996) Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. Circulation 94:52–60
Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr, Tajik AJ (1996) Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 28(5):1226–1233
Ito T, Suwa M, Kobashi A, Nakamura T, Miyazaki S, Hirota Y (2000) Prediction of mean pulmonary wedge pressure using Doppler pulmonary venous flow variables in hypertrophic cardiomyopathy. Int J Cardiol 76:49–56
Nagueh SF, Lakkis NM, Middleton KJ, Spencer WH 3rd, Zoghbi WA, Quiñones MA (1999) Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99:254–261
Wang J, Khoury DS, Thohan V, Torre-Amione G, Nagueh SF (2007) Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation 115:1376–1383
Bednarz J, Vignon P, Mor-Avi VV, Weinert L, Koch R, Spencer K, Lang RM (1998) Color kinesis: principles of operation and technical guidelines. Echocardiography 15:21–34
Vignon P, Mor-Avi V, Weinert L, Koch R, Spencer KT, Lang RM (1998) Quantitative evaluation of global and regional left ventricular diastolic function with color kinesis. Circulation 97:1053–1061
Ito T, Suwa M, Imai M, Nakamura T, Kitaura Y (2004) Assessment of regional left ventricular filling dynamics using color kinesis in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 17:146–151
Yuan J, Chen S, Qiao S, Duan F, Zhang J, Wang H (2014) Characteristics of myocardial postsystolic shortening in patients with symptomatic hypertrophic obstructive cardiomyopathy before and half a year after alcohol septal ablation assessed by speckle tracking echocardiography. PLoS One 9:e99014. https://doi.org/10.1371/journal.pone.0099014
Elsheshtawy MO, Mahmoud AN, Abdelghany M, Suen IH, Sadiq A, Shani J (2018) Left ventricular aneurysms in hypertrophic cardiomyopathy with midventricular obstruction: a systematic review of literature. Pacing Clin Electrophysiol 41:854–865. https://doi.org/10.1111/pace.13380
Støylen A, Sletvold O, Skjaerpe T (2003) Post systolic shortening in nonobstructive hypertrophic cardiomyopathy with delayed emptying of the apex: a Doppler flow, tissue Doppler and strain rate imaging case study. Echocardiography 20:167–171
Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287:1308–1320
Giraldeau G, Duchateau N, Bijnens B, Gabrielli L, Penela D, Evertz R, Mont L, Brugada J, Berruezo A, Sitges M (2016) Dyssynchronization reduces dynamic obstruction without affecting systolic function in patients with hypertrophic obstructive cardiomyopathy: a pilot study. Int J Card Imaging 32:1179–1188. https://doi.org/10.1007/s10554-016-0903-3
Ito T, Suwa M, Sakai Y, Hozumi T, Kitaura Y (2005) Usefulness of tissue Doppler imaging for demonstrating altered septal contraction sequence during dual-chamber pacing in obstructive hypertrophic cardiomyopathy. Am J Cardiol 96:1558–1562
Hozumi T, Ito T, Suwa M, Sakai Y, Kitaura Y (2006) Effects of dual-chamber pacing on regional myocardial deformation in patients with hypertrophic obstructive cardiomyopathy. Circ J 70:63–68
Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM (2006) Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J 27:1805–1810
Finocchiaro G, Haddad F, Kobayashi Y, Lee D, Pavlovic A, Schnittger I, Sinagra G, Magavern E, Myers J, Froelicher V, Knowles JW, Ashley E (2016) Impact of septal reduction on left atrial size and diastole in hypertrophic cardiomyopathy. Echocardiography 33:686–694. https://doi.org/10.1111/echo.13158
Ommen SR, Nishimura RA, Squires RW, Schaff HV, Danielson GK, Tajik AJ (1999) Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points. J Am Coll Cardiol 34:191–196
Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR Jr, Tajik AJ (1996) Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy. Acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 27:421–430
Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, Spencer WH 3rd (1999) Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 34:1123–1128
Angermann CE, Nassau K, Stempfle HU, Krüger TM, Drewello R, Junge R, Uberfuhr P, Weiss M, Theisen K (1997) Recognition of acute cardiac allograft rejection from serial integrated backscatter analyses in human orthotopic heart transplant recipients. Comparison with conventional echocardiography. Circulation 95:140–150
Suwa M, Ito T, Kobashi A, Yagi H, Terasaki F, Hirota Y, Kawamura K (2000) Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: prediction of response to beta-blocker therapy. Am Heart J 139:905–912
Suwa M, Ito T, Nakamura T, Miyazaki S (2002) Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy. Int J Cardiol 84:133–140
Naito J, Masuyama T, Tanouchi J, Mano T, Kondo H, Yamamoto K, Nagano R, Hori M, Inoue M, Kamada T (1994) Analysis of transmural trend of myocardial integrated ultrasound backscatter for differentiation of hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension. J Am Coll Cardiol 24:517–524
Maron BJ, Maron MS (2013) Hypertrophic cardiomyopathy. Lancet 381:242–255. https://doi.org/10.1016/S0140-6736(12)60397-3
Bulluck H, Maestrini V, Rosmini S, Abdel-Gadir A, Treibel TA, Castelletti S, Bucciarelli-Ducci C, Manisty C, Moon JC (2015) Myocardial T1 mapping. Circ J 79:487–494. https://doi.org/10.1253/circj.CJ-15-0054
Ogawa R, Kido T, Nakamura M, Kido T, Kurata A, Uetani T, Ogimoto A, Miyagawa M, Mochizuki T (2017) T1 mapping using saturation recovery single-shot acquisition at 3-tesla magnetic resonance imaging in hypertrophic cardiomyopathy: comparison to late gadolinium enhancement. Jpn J Radiol 35:116–125. https://doi.org/10.1007/s11604-017-0611-5
Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO (2015, 2015) T1 mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the international T1 multicenter cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 8. https://doi.org/10.1161/CIRCIMAGING.115.003285
Falk RH, Quarta CC (2015) Echocardiography in cardiac amyloidosis. Heart Fail Rev 20:125–131. https://doi.org/10.1007/s10741-014-9466-3
Phelan D, Thavendiranathan P, Popovic Z, Collier P, Griffin B, Thomas JD, Marwick TH (2014) Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy. J Am Soc Echocardiogr 27:888–895. https://doi.org/10.1016/j.echo.2014.04.015
Schiano-Lomoriello V, Galderisi M, Mele D, Esposito R, Cerciello G, Buonauro A, Della Pepa R, Picardi M, Catalano L, Trimarco B, Pane F (2016) Longitudinal strain of left ventricular basal segments and E/e’ ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study. Echocardiography 33:1335–1343. https://doi.org/10.1111/echo.13278
Koyama J, Ray-Sequin PA, Falk RH (2003) Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 107:2446–1452
Baccouche H, Maunz M, Beck T, Gaa E, Banzhaf M, Knayer U, Fogarassy P, Beyer M (2012) Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography 29:668–677. https://doi.org/10.1111/j.1540-8175.2012.01680.x
de Gregorio C, Dattilo G, Casale M, Terrizzi A, Donato R, Di Bella G (2014) Left atrial morphology, size and function in patients with transthyretin cardiac amyloidosis and primary hypertrophic cardiomyopathy - comparative strain imaging study. Circ J 80:1830–1837. https://doi.org/10.1253/circj.CJ-16-0364
Nochioka K, Quarta CC, Claggett B, Roca GQ, Rapezzi C, Falk RH, Solomon SD (2017) Left atrial structure and function in cardiac amyloidosis. Eur Heart J Cardiovasc Imaging 18:1128–1137. https://doi.org/10.1093/ehjci/jex097
Földeák D, Kormányos Á, Domsik P, Kalapos A, Piros GÁ, Ambrus N, Ajtay Z, Sepp R, Borbényi Z, Forster T, Nemes A (2017) Left atrial dysfunction in light-chain cardiac amyloidosis and hypertrophic cardiomyopathy - a comparative three-dimensional speckle-tracking echocardiographic analysis from the MAGYAR-path study. Rev Port Cardiol 36:905–913. https://doi.org/10.1016/j.repc.2017.06.014
Mohty D, Petitalot V, Magne J, Fadel BM, Boulogne C, Rouabhia D, ElHamel C, Lavergne D, Damy T, Aboyans V, Jaccard A (2018) Left atrial function in patients with light chain amyloidosis: a transthoracic 3D speckle tracking imaging study. J Cardiol 71:419–427. https://doi.org/10.1016/j.jjcc.2017.10.007
Ari H, Ari S, Akkaya M, Aydin C, Emlek N, Sarigül OY, Çetinkaya S, Bozat T, Şentürk M, Karaağaç K, Melek M, Yilmaz M (2013) Predictive value of atrial electromechanical delay for atrial fibrillation recurrence. Cardiol J 20:639–647. https://doi.org/10.5603/CJ.2013.0164
Hoshi Y, Nozawa Y, Ogasawara M, Yuda S, Sato S, Sakasai T, Oka M, Katayama H, Sato M, Kouzu H, Nishihara M, Doi A, Nishimiya T, Miura T (2014) Atrial electromechanical interval may predict cardioembolic stroke in apparently low risk elderly patients with paroxysmal atrial fibrillation. Echocardiography 31:140–148. https://doi.org/10.1111/echo.12329
Iio C, Inoue K, Nishimura K, Fujii A, Nagai T, Suzuki J, Okura T, Higaki J, Ogimoto A (2015) Characteristics of left atrial deformation parameters and their prognostic impact in patients with pathological left ventricular hypertrophy: analysis by speckle tracking echocardiography. Echocardiography 32:1821–1830. https://doi.org/10.1111/echo.12961
Acknowledgments
We are grateful to Keiji Nishimura of Osaka Medical College Hospital for his echocardiographic expertise and Yumiko Kanzaki of Department of Cardiology in Osaka Medical College for her CMR expertise and for assistance with the figures.
Author information
Authors and Affiliations
Contributions
TI was involved in the design and writing of the article, and MS in drafting and revising for important intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ito, T., Suwa, M. Echocardiographic tissue imaging evaluation of myocardial characteristics and function in cardiomyopathies. Heart Fail Rev 26, 813–828 (2021). https://doi.org/10.1007/s10741-020-09918-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10741-020-09918-y